RFP | March 29, 2011
U.S. Department of Health and Human Services, National Heart, Lung, and Blood Institute, National Institutes of Health announces the availability of funding for implementation of the Translation of Pluripotent Stem Cell Therapies for Blood Diseases Grant to provide research for the development of new technologies needed to utilize stem cells in future cell therapies to treat sickle cell disease and other blood disorders. Contractors should refer to Section VII, Financial/Grants Management Contacts in the RFP for information regarding each Institute's grants management contact and due date for this program . . .